Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer.

Journal:

Journal of Clinical Oncology

Published:

2026-02-12

DOI:

10.1200/jco-25-02199

Affiliations:

16

Authors:

36

Go to article

Institutions	Authors	Share
Valar Labs, United States of America (USA)	11.500000 11.500000	0.32
Cedars-Sinai Medical Center (Cedars-Sinai), United States of America (USA)	5.000000	0.14
Princess Margaret Cancer Centre, U of T, Canada	4.333333	0.12
Pancreatic Cancer Action Network (PanCAN), United States of America (USA)	3.000000	0.08
Oregon Health and Science University (OHSU), United States of America (USA)	2.000000	0.06
Georgetown Lombardi Comprehensive Cancer Center, United States of America (USA)	2.000000	0.06
University of Pittsburgh Medical Center (UPMC), United States of America (USA)	2.000000	0.06
Fred Hutchinson Cancer Center, United States of America (USA)	1.000000	0.03
University of Cincinnati (UC), United States of America (USA)	1.000000	0.03
Roswell Park Cancer Institute (RPCI), United States of America (USA)	1.000000	0.03
St. Vincent's University Hospital, Ireland	1.000000	0.03
Essen University Hospital, Germany	0.666667	0.02
Wake Forest University (WFU), United States of America (USA)	0.500000	0.01
University of Illinois at Chicago (UIC), United States of America (USA)	0.500000	0.01
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)	0.500000	0.01

Interested in Oncology and Carcinogenesis?